Researchers around the world are trying all possible means to find a solution to the COVID-19 pandemic. In clinical trials some medications used for the treatment of other ailments have also shown promising results for the treatment of coronavirus patients. Itolizumab a drug used to cure skin ailment psoriasis is one such medication. Based on promising clinical trial data the Drugs Controller General of India (DCGI) has approved restricted emergency use of Itolizumab injection for treating COVID-19 patients with moderate to severe acute respiratory distress. The drug manufactured and marketed by Biocon has been in use since 2013 under the